Advertisement Prior studies upheld the benefits of psilocybin for treatment-resistant depression, and the Food and Drug Administration at some point will be asked to approve this psychedelic -- a ...
Among these emerging therapies, psychedelic retreats have gained significant interest as a modality. Retreats are short-term inpatient treatment programs that provide a deepened wellness ...
Trippy's Smoke Shop owner Tariq Bayoud bought a building that formerly housed a Taco Luchador for $1.1 million in June, with plans to open a new store there. However, city officials said opening ...
The mushroom underground perceives these trap mushroom bars as muscling in on their territory and trying to hitch their wagons to the psychedelic boom—and they’re correct on the second point.
Several key figures stand out in their efforts to push forward the advancement of psychedelic medicine, in the face of ongoing controversy, regulatory hurdles, and stigma. Psychiatric medicine ...
But Mike Tyson generated buzz during a recent appearance on Logan Paul's podcast when he said he consumes mushrooms of the psychedelic variety while he's training for his fight against Jake Paul ...
“I see turtles,” says Molly Coghill. Not in real life — although, sometimes, she does — but in the visions brought on by using psychedelic drugs. “A lot of people have trip animals,” Coghill says. “I ...
Psychedelic-assisted therapy, by contrast, seems to help "lift the veil" and allow people to have insights—"lightbulb moments"—that aid in their recovery, Morisano explained.
But with a complex legal landscape and a need for more research, the ostensibly promising world of psychedelic therapy remains largely uncharted. Here’s a quick rundown of what we know about ...
Millions of Americans struggling with depression could benefit from the active ingredient in magic mushrooms, new research suggests. However, approval of such treatments will depend on the U.S ...
There's more bad news for the company behind an experimental MDMA therapy for post-traumatic stress disorder, which the Food and Drug Administration roundly rejected earlier this month. According ...
Rick Doblin spent more than 30 years trying to turn the psychedelic drug MDMA into an accepted medical treatment for post-traumatic stress disorder. Earlier this month, the Food and Drug ...